Literature DB >> 31765790

Prenatal opioid exposure: The next neonatal neuroinflammatory disease.

Lauren L Jantzie1, Jessie R Maxwell2, Jessie C Newville2, Tracylyn R Yellowhair3, Yuma Kitase4, Nethra Madurai4, Sindhu Ramachandra4, Ludmila N Bakhireva5, Frances J Northington4, Gwendolyn Gerner6, Aylin Tekes7, Lorraine A Milio8, Jonathan L Brigman9, Shenandoah Robinson3, Andrea Allan9.   

Abstract

The rates of opioid use disorder during pregnancy have more than quadrupled in the last decade, resulting in numerous infants suffering exposure to opioids during the perinatal period, a critical period of central nervous system (CNS) development. Despite increasing use, the characterization and definition of the molecular and cellular mechanisms of the long-term neurodevelopmental impacts of opioid exposure commencing in utero remains incomplete. Thus, in consideration of the looming public health crisis stemming from the multitude of infants with prenatal opioid exposure entering school age, we undertook an investigation of the effects of perinatal methadone exposure in a novel preclinical model. Specifically, we examined the effects of opioids on the developing brain to elucidate mechanisms of putative neural cell injury, to identify diagnostic biomarkers and to guide clinical studies of outcome and follow-up. We hypothesized that methadone would induce a pronounced inflammatory profile in both dams and their pups, and be associated with immune system dysfunction, sustained CNS injury, and altered cognition and executive function into adulthood. This investigation was conducted using a combination of cellular, molecular, biochemical, and clinically translatable biomarker, imaging and cognitive assessment platforms. Data reveal that perinatal methadone exposure increases inflammatory cytokines in the neonatal peripheral circulation, and reprograms and primes the immune system through sustained peripheral immune hyperreactivity. In the brain, perinatal methadone exposure not only increases chemokines and cytokines throughout a crucial developmental period, but also alters microglia morphology consistent with activation, and upregulates TLR4 and MyD88 mRNA. This increase in neuroinflammation coincides with reduced myelin basic protein and altered neurofilament expression, as well as reduced structural coherence and significantly decreased fractional anisotropy on diffusion tensor imaging. In addition to this microstructural brain injury, adult rats exposed to methadone in the perinatal period have significant impairment in associative learning and executive control as assessed using touchscreen technology. Collectively, these data reveal a distinct systemic and neuroinflammatory signature associated with prenatal methadone exposure, suggestive of an altered CNS microenvironment, dysregulated developmental homeostasis, complex concurrent neural injury, and imaging and cognitive findings consistent with clinical literature. Further investigation is required to define appropriate therapies targeted at the neural injury and improve the long-term outcomes for this exceedingly vulnerable patient population.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognition; Diffusion tensor imaging; Methadone; Microglia; Pregnancy; White matter

Year:  2019        PMID: 31765790      PMCID: PMC7010550          DOI: 10.1016/j.bbi.2019.11.007

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  24 in total

1.  Prenatal opioid exposure inhibits microglial sculpting of the dopamine system selectively in adolescent male offspring.

Authors:  Caroline J Smith; Tania Lintz; Staci D Bilbo; Elena H Chartoff; Madeline J Clark; Karen E Malacon; Alia Abiad; Nicholas J Constantino; Veronica J Kim; Young C Jo; Yanaira Alonso-Caraballo
Journal:  Neuropsychopharmacology       Date:  2022-07-14       Impact factor: 8.294

2.  Perinatal Morphine Exposure Leads to Sex-Dependent Executive Function Deficits and Microglial Changes in Mice.

Authors:  Brittany L Smith; Tess A Guzman; Alexander H Brendle; Collin J Laaker; Alexis Ford; Adam R Hiltz; Junfang Zhao; Kenneth D R Setchell; Teresa M Reyes
Journal:  eNeuro       Date:  2022-10-17

3.  Perinatal methadone exposure attenuates myelination and induces oligodendrocyte apoptosis in neonatal rat brain.

Authors:  Jennifer M Gibson; Tianci Chu; Wenxin Zeng; Ashley C Wethall; Maiying Kong; Nicholas Mellen; Lori A Devlin Phinney; Jun Cai
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

Review 4.  Understanding Vulnerability and Adaptation in Early Brain Development using Network Neuroscience.

Authors:  Alice M Graham; Mollie Marr; Claudia Buss; Elinor L Sullivan; Damien A Fair
Journal:  Trends Neurosci       Date:  2021-03-01       Impact factor: 13.837

Review 5.  Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.

Authors:  Yaa Abu; Sabita Roy
Journal:  Exp Neurol       Date:  2021-01-29       Impact factor: 5.330

Review 6.  Neuroimaging in infants with prenatal opioid exposure: Current evidence, recent developments and targets for future research.

Authors:  Rupa Radhakrishnan; Gregory Grecco; Kellen Stolze; Brady Atwood; Samuel G Jennings; Izlin Z Lien; Andrew J Saykin; Senthilkumar Sadhasivam
Journal:  J Neuroradiol       Date:  2020-10-13       Impact factor: 3.447

Review 7.  Endogenous and exogenous opioid effects on oligodendrocyte biology and developmental brain myelination.

Authors:  Brandon Velasco; Esraa Mohamed; Carmen Sato-Bigbee
Journal:  Neurotoxicol Teratol       Date:  2021-06-12       Impact factor: 4.071

8.  Co-occurrence of preconception maternal childhood adversity and opioid use during pregnancy: Implications for offspring brain development.

Authors:  Madeleine C Allen; Nora K Moog; Claudia Buss; Elizabeth Yen; Hanna C Gustafsson; Elinor L Sullivan; Alice M Graham
Journal:  Neurotoxicol Teratol       Date:  2021-09-30       Impact factor: 4.071

Review 9.  Neonatal opioid exposure: public health crisis and novel neuroinflammatory disease.

Authors:  Vikram Vasan; Yuma Kitase; Jessie C Newville; Shenandoah Robinson; Gwendolyn Gerner; V Joanna Burton; Lauren L Jantzie
Journal:  Neural Regen Res       Date:  2021-03       Impact factor: 5.135

10.  Interleukin-10 deficiency exacerbates inflammation-induced tau pathology.

Authors:  Lea L Weston; Shanya Jiang; Devon Chisholm; Lauren L Jantzie; Kiran Bhaskar
Journal:  J Neuroinflammation       Date:  2021-07-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.